These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35797687)

  • 1. A Retrospective Study of the Adjunctive Use of Gabapentin With Benzodiazepines for the Treatment of Benzodiazepine Withdrawal.
    Leung E; Ngo DH; Espinoza JA; Beal LL; Chang C; Baris DA; Lackey BN; Lane SD; Wu HE
    J Psychiatr Pract; 2022 Jul; 28(4):310-318. PubMed ID: 35797687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Gabapentin as a Benzodiazepine-Sparing Agent in Alcohol Withdrawal Syndrome.
    Alzghoul H; Al-Said MI; Obeidat O; Al-Ani H; Tarawneh M; Meadows R; Youness H; Reddy R; Al-Jafari M; Alzghoul BN; Khan A
    Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929621
    [No Abstract]   [Full Text] [Related]  

  • 3. Gabapentin to treat acute alcohol withdrawal in hospitalized patients: A systematic review and meta-analysis.
    Mattle AG; McGrath P; Sanu A; Kunadharaju R; Kersten B; Zammit K; Mammen MJ
    Drug Alcohol Depend; 2022 Dec; 241():109671. PubMed ID: 36402053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
    McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
    J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
    DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
    Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
    [No Abstract]   [Full Text] [Related]  

  • 6. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.
    Smith JT; Sage M; Szeto H; Myers LC; Lu Y; Martinez A; Kipnis P; Liu VX
    JAMA Netw Open; 2022 Feb; 5(2):e220158. PubMed ID: 35191968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal.
    Morrison M; Udeh E; Burak M
    Am J Drug Alcohol Abuse; 2019; 45(4):385-391. PubMed ID: 30990361
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service.
    Leung JG; Rakocevic DB; Allen ND; Handler EM; Perossa BA; Borreggine KL; Stark AL; Betcher HK; Hosker DK; Minton BA; Braus BR; Dierkhising RA; Philbrick KL
    Psychosomatics; 2018; 59(5):496-505. PubMed ID: 29735241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.
    Mariani JJ; Malcolm RJ; Mamczur AK; Choi JC; Brady R; Nunes E; Levin FR
    Am J Drug Alcohol Abuse; 2016 May; 42(3):333-40. PubMed ID: 26962719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital.
    Vadiei N; Smith TL; Walton AE; Kjome KL
    Psychopharmacol Bull; 2019 Feb; 49(1):17-27. PubMed ID: 30858636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients.
    Youland KM; Miller RF; Mahoney LJ; Borgert AJ; Gundrum JD
    J Clin Psychopharmacol; 2014 Dec; 34(6):704-8. PubMed ID: 25144138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Evaluation of Adjunctive Phenobarbital vs. Benzodiazepine Alone for the Treatment of Moderate Alcohol Withdrawal in the Emergency Department.
    Lebin JA; Bass ME; Heard K; Hoppe J; Jacknin G
    J Emerg Med; 2024 Apr; 66(4):e516-e522. PubMed ID: 38485572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility.
    Nichols TA; Robert S; Taber DJ; Cluver J
    Ment Health Clin; 2019 Jan; 9(1):1-5. PubMed ID: 30627496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome.
    Malone D; Costin BN; MacElroy D; Al-Hegelan M; Thompson J; Bronshteyn Y
    Neuropsychopharmacol Rep; 2023 Dec; 43(4):532-541. PubMed ID: 37368937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Gabapentin and Baclofen Combination for Inpatient Management of Alcohol Withdrawal Syndrome.
    Karapetyan K; Rosenfeldt Z; Caniff K
    Fed Pract; 2023 Apr; 40(4):128-133. PubMed ID: 37223663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.